Profile
ACE & Company is a private equity and venture capital firm based in Geneva, Switzerland, founded in 2005. The firm operates with a team of 16 professionals and has a global presence with offices in Geneva, Zurich, New York, London, and Cairo. ACE & Company is known for its focus on overlooked segments of private markets, leveraging its extensive network and experience to identify unique investment opportunities.
The firm invests across various sectors including healthcare services, information technology, financial services, and energy services. ACE & Company manages over $2 billion in assets and engages in both early to late-stage technology investments through its ACE Ventures arm, as well as lower mid-market buyouts and secondary investments through its private equity division. The firm typically leads Seed and Series A rounds and has supported 13 unicorns.
Notable investments by ACE & Company include InterPur Chemicals - distributors/wholesale, Diponio Contracting - construction and engineering, Day Dermatology & Aesthetics - healthcare services, Humphrey & Beleznay Cosmetic Dermatology - personal products, and Marmur Medical - clinics/outpatient services.
Industry
ACE and Company Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
ACE and Company Fund
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
SaaS
Security
Software
Transportation
Energy
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$244 M
|
December 2021
|
|
ACE Buyout Opportunities V
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Financial Services
Fintech
Healthcare Services
Retail
SaaS
Security
Software
Technology
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$244 M
|
December 2023
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.